鼻内镜在治疗嗅沟脑膜瘤中的局限性:一项系统综述
该系统综述检索2011至2016年文献,比较内镜下鼻内入路(EEA)与经颅入路(TCA)治疗嗅沟脑膜瘤的切除程度、视力结局、并发症与复发率。TCA组444例、EEA组101例,TCA全切除率90.9%高于EEA的70.2%(p<0.0001),EEA脑脊液漏与脑膜炎发生率更高。作者认为多数嗅沟脑膜瘤仍宜采用TCA。
要点
- TCA组全切除率90.9%(404/444)高于EEA组70.2%(71/101),p<0.0001。
- 术前视力障碍者EEA组视力改善80.7%(21/26)高于TCA组12.83%(29/226),p<0.0001。
- EEA组脑脊液漏25.7%、脑膜炎4.95%,分别高于TCA组的6.3%与1.12%。
核心结论
- 尽管内镜切除与颅底重建经验增加,文献仍支持TCA在切除程度与并发症方面优于EEA。
- EEA可作为视力改善为主要手术目标且患者可接受术后嗅觉丧失的选择性病例的选项,或用于术前已存在嗅觉丧失的中等大小肿瘤。
- 基于本研究结果,目前对多数嗅沟脑膜瘤采用TCA似乎更为审慎。
研究设计与样本
- 系统综述,检索PubMed 2011至2016年文献,比较EEA与TCA治疗嗅沟脑膜瘤的结局。
- TCA组444例,肿瘤平均直径4.61(±1.17)cm;EEA组101例,肿瘤平均直径3.55(±0.58)cm(p=0.0589)。
- 采用百分比与比例、Fischer精确检验和Student t检验,使用Graphpad PRISM 7.0Aa软件分析。
主要发现
- 全切除TCA组90.9%(404/444)vs EEA组70.2%(71/101),p<0.0001。
- 术前视力障碍患者视力改善EEA组80.7%(21/26)vs TCA组12.83%(29/226),p<0.0001。
- 嗅觉丧失TCA组61% vs EEA组100%。
- 脑脊液漏EEA组25.7% vs TCA组6.3%(p<0.0001);脑膜炎EEA组4.95% vs TCA组1.12%(p=0.023)。
临床怎么用
- 作者认为目前对多数嗅沟脑膜瘤采用TCA似乎更为审慎。
- 作者认为EEA可用于视力改善为主要目标且术后嗅觉丧失可接受的选择性病例,或用于术前已存在嗅觉丧失的中等大小肿瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To review current management strategies for olfactory groove meningioma (OGM)s and the recent literature comparing endoscopic endonasal (EEA) with traditional transcranial (TCA) approaches. METHODS: A PubMed search of the recent literature (2011-2016) was performed to examine outcomes following EEA and TCA for OGM. The extent of resection, visual outcome, postoperative complications and recurrence rates were analyzed using percentages and proportions, the Fischer exact test and the Student's t-test using Graphpad PRISM 7.0Aa (San Diego, CA) software. RESULTS: There were 444 patients in the TCA group with a mean diameter of 4.61 (±1.17) cm and 101 patients in the EEA group with a mean diameter of 3.55 (± 0.58) cm (p = 0.0589). GTR was achieved in 90.9% (404/444) in the TCA group and 70.2% (71/101) in the EEA group (p < 0.0001). Of the patients with preoperative visual disturbances, 80.7% (21/26) of patients in the EEA cohort had an improvement in vision compared to 12.83%(29/226) in the TCA group (p < 0.0001). Olfaction was lost in 61% of TCA and in 100% of EEA patients. CSF leaks and meningitis occurred in 25.7% and 4.95% of EEA patients and 6.3% and 1.12% of TCA patients, respectively (p < 0.0001; p = 0.023). CONCLUSIONS: Our updated literature review demonstrates that despite more experience with endoscopic resection and skull base reconstruction, the literature still supports TCA over EEA with respect to the extent of resection and complications. EEA may be an option in selected cases where visual improvement is the main goal of surgery and postoperative anosmia is acceptable to the patient or in medium-sized tumors with existing preoperative anosmia. Nevertheless, based on our results, it seems more prudent at this time to use TCA for the majority of OGMs.
引用
- Shetty SR, Ruiz-Treviño AS, Omay SB, et al. Limitations of the endonasal endoscopic approach in treating olfactory groove meningiomas. A systematic review. Acta Neurochir (Wien). 2017. PMID: 28831590. doi:10.1007/s00701-017-3303-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。